V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20211058 | 20078482 | null | null | Palliative (P) | 2019-10-29 | 2019-11-25 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101618383 |
| 20211060 | 20078483 | 0 | 0 | Palliative (P) | 2020-11-07 | 2020-11-19 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101236585 |
| 20211062 | 20078484 | 1.87 | 94.2 | Palliative (P) | 2019-05-27 | 2019-06-05 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 100301124 |
| 20211071 | 20078485 | 1.75 | 71.8 | 03 | 2016-08-22 | 2016-09-17 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101811968 |
| 20211074 | 20078486 | 1.7 | 50.2 | Curative (C) | 2018-01-20 | 2018-02-25 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100919026 |
| 20211076 | 20078487 | 1.78 | 79.6 | Curative (C) | 2015-10-14 | 2015-10-14 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | CISPLATIN + FLUOROURACIL | 100136136 |
| 20211086 | 20078488 | 1.63 | 63.6 | Palliative (P) | 2016-05-17 | 2016-05-17 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100640647 |
| 20211094 | 20078489 | 0 | 0 | null | 2018-03-19 | 2018-03-25 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 100951667 |
| 20211105 | 20078490 | 1.87 | 91 | Neo-adjuvant (N) | 2016-07-26 | 2016-08-15 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 101269323 |
| 20211107 | 20078491 | 1.64 | 79 | Palliative (P) | 2017-06-13 | 2017-06-13 | CAPECITABINE + CARBOPLATIN | N | N | TRIAL UNSPECIFIED | 101281045 |
| 20211108 | 20078492 | 1.85 | 82.4 | Neo-adjuvant (N) | 2017-09-29 | 2017-10-11 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100305103 |
| 20211110 | 20078493 | 1.52 | 110 | Neo-adjuvant (N) | 2016-07-23 | 2016-07-31 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100180778 |
| 20211114 | 20078494 | 1.66 | 56.3 | Palliative (P) | 2017-04-25 | 2017-05-30 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100738786 |
| 20211119 | 20078495 | 0 | 0 | Palliative (P) | 2017-04-03 | 2017-04-17 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101094744 |
| 20211126 | 20078496 | 1.66 | 49.3 | Neo-adjuvant (N) | 2018-02-22 | 2018-03-03 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100179824 |
| 20211127 | 20078497 | 1.69 | 75.4 | Curative (C) | 2020-01-02 | 2020-01-13 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100870910 |
| 20211128 | 20078498 | 1.78 | 102 | Palliative (P) | 2017-03-13 | 2017-03-21 | Capecitabine + Carboplatin + RT | 02 | null | TRIAL UNSPECIFIED | 100056162 |
| 20211131 | 20078499 | 1.78 | 71.6 | Neo-adjuvant (N) | 2019-09-20 | 2019-10-05 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100965481 |
| 20211135 | 20078500 | 1.68 | null | Curative (C) | 2018-07-06 | 2018-07-22 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101493740 |
| 20211151 | 20078501 | 1.79 | 63.4 | Curative (C) | 2019-01-19 | 2019-01-19 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101773810 |
| 20211152 | 20078502 | 1.78 | 93.5 | Palliative (P) | 2018-07-02 | 2018-07-04 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100244150 |
| 20211155 | 20078503 | 1.9 | 78.9 | Neo-adjuvant (N) | null | 2016-11-24 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101742599 |
| 20211156 | 20078504 | 1.82 | 110.7 | Curative (C) | 2019-07-01 | 2019-07-19 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101759437 |
| 20211159 | 20078505 | 1.81 | 77.65 | Palliative (P) | 2019-09-27 | 2019-10-03 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101609075 |
| 20211161 | 20078506 | 1.87 | 69.3 | Palliative (P) | 2019-07-08 | 2019-07-12 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100991438 |
| 20211164 | 20078508 | 1.63 | 83.4 | Neo-adjuvant (N) | 2015-05-21 | 2015-05-23 | Cisplatin +Fluorouracil (3 wk) | 2 | N | CISPLATIN + FLUOROURACIL | 100187885 |
| 20211167 | 20078509 | 1.54 | 99 | Palliative (P) | 2016-09-11 | 2016-09-13 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100020857 |
| 20211168 | 20078510 | 1.65 | 54.8 | Palliative (P) | 2018-06-24 | 2018-07-15 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100605423 |
| 20211169 | 20078511 | 1.65 | 80.2 | Adjuvant (A) | 2017-12-13 | 2017-12-27 | Capecitabine (21days) + Carboplatin | N | N | CISPLATIN + FLUOROURACIL | 101578880 |
| 20211173 | 20078512 | 1.55 | 63.9 | Neo-adjuvant (N) | 2017-09-28 | 2017-10-02 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101664321 |
| 20211185 | 20078513 | null | 89.3 | Palliative (P) | 2018-05-29 | 2018-06-01 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101339493 |
| 20211186 | 20078514 | 1.67 | 78.2 | Palliative (P) | 2016-12-21 | 2016-12-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101099748 |
| 20211187 | 20078515 | 1.58 | 50.9 | Neo-adjuvant (N) | 2019-06-22 | 2019-06-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101066136 |
| 20211189 | 20078516 | null | null | null | null | 2017-05-04 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100986067 |
| 20211191 | 20078517 | 1.68 | 68.5 | Neo-adjuvant (N) | 2018-02-27 | 2018-02-27 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100939160 |
| 20211196 | 20078518 | 0 | 0 | null | 2016-05-11 | 2016-06-01 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100341823 |
| 20211197 | 20078519 | 1.63 | 88.2 | Palliative (P) | 2017-01-08 | 2017-01-12 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100175208 |
| 20211200 | 20078520 | 1.85 | 54.8 | Palliative (P) | 2018-01-31 | 2018-02-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101696792 |
| 20211202 | 20078521 | 1.6 | 69.6 | Palliative (P) | 2019-11-11 | 2019-11-30 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100541137 |
| 20211204 | 20078522 | 1.75 | null | Adjuvant (A) | 2019-02-17 | 2019-03-01 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100023194 |
| 20211205 | 20078523 | null | 82.6 | Palliative (P) | null | 2020-07-20 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 101774234 |
| 20211206 | 20078524 | 1.52 | 70.05 | Palliative (P) | 2019-11-27 | 2019-11-30 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 101013569 |
| 20211209 | 20078525 | 1.76 | 67 | null | 2019-03-23 | 2019-03-24 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100614995 |
| 20211213 | 20078526 | 1.78 | 75.4 | 03 | 2019-10-28 | 2019-10-29 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101280605 |
| 20211214 | 20078527 | 0 | 70.2 | Adjuvant (A) | 2018-11-14 | 2018-11-29 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100113807 |
| 20211216 | 20078528 | 1.73 | 72.1 | Palliative (P) | 2017-09-13 | 2017-09-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100136466 |
| 20211218 | 20078529 | 1.59 | 71.8 | Palliative (P) | 2018-01-10 | 2018-01-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100859166 |
| 20211219 | 20078530 | 1.85 | 112 | Palliative (P) | 2017-01-14 | 2017-02-07 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101050041 |
| 20211223 | 20078531 | 1.79 | 47 | Palliative (P) | 2018-10-31 | 2018-11-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101189446 |
| 20211225 | 20078532 | 1.5 | 54.75 | Neo-adjuvant (N) | 2018-02-12 | 2018-02-13 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100892735 |